142 related articles for article (PubMed ID: 19581320)
1. US senator seeks information about medical faculty links to drug industry.
Tanne JH
BMJ; 2009 Jul; 339():b2725. PubMed ID: 19581320
[No Abstract] [Full Text] [Related]
2. Few US medical schools and medical centres are disclosing industry ties.
Tanne JH
BMJ; 2010 Feb; 340():c1075. PubMed ID: 20179129
[No Abstract] [Full Text] [Related]
3. Medical professionalism--focusing on the real issues.
Ruane TJ
N Engl J Med; 2000 Sep; 343(10):739-40. PubMed ID: 10979775
[No Abstract] [Full Text] [Related]
4. Harnessing the profit motive.
Lancet; 1995 May; 345(8959):1189-90. PubMed ID: 7739301
[No Abstract] [Full Text] [Related]
5. Changing patterns of biomedical research funding: a view from the medical school.
Robbins FC
Clin Res; 1982 Sep; 30(3):302-7. PubMed ID: 10256472
[No Abstract] [Full Text] [Related]
6. Collaborating with industry--choices for the academic medical center.
Moses H; Braunwald E; Martin JB; Thier SO
N Engl J Med; 2002 Oct; 347(17):1371-5. PubMed ID: 12397200
[No Abstract] [Full Text] [Related]
7. Medical-research ethics under the microscope: schools try to plot the fine line between commercial links and conflicts of interest.
Mangan KS
Chron High Educ; 2003 Jul; 49(46):A22-4. PubMed ID: 15287130
[No Abstract] [Full Text] [Related]
8. Under the influence? Study finds medical schools taking industry cash.
Rhea S
Mod Healthc; 2007 Oct; 37(42):14-5. PubMed ID: 18027477
[No Abstract] [Full Text] [Related]
9. Medical schools found to vary in their drug-testing standards.
Dean C
N Y Times Web; 2005 May; ():A24. PubMed ID: 15981393
[No Abstract] [Full Text] [Related]
10. Industrial collaboration.
Rosoff PM
N Engl J Med; 2003 Feb; 348(9):863-4; author reply 863-4. PubMed ID: 12606747
[No Abstract] [Full Text] [Related]
11. US medical schools should say no to pharma support.
Tanne JH
BMJ; 2008 May; 336(7652):1035. PubMed ID: 18467393
[No Abstract] [Full Text] [Related]
12. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
Tereskerz PM
Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
[No Abstract] [Full Text] [Related]
13. Conflict-of-interest policies.
Topol EJ
N Engl J Med; 2001 Mar; 344(13):1017; author reply 1018. PubMed ID: 11280315
[No Abstract] [Full Text] [Related]
14. The destruction of medicine by market forces: teaching acquiescence or resistance and change?
Wolfe SM
Acad Med; 2002 Jan; 77(1):5-7. PubMed ID: 11788316
[No Abstract] [Full Text] [Related]
15. The pharma industry--redressing the balance.
Panay N; Fenton A
Climacteric; 2008 Oct; 11(5):353-4. PubMed ID: 18781478
[No Abstract] [Full Text] [Related]
16. Exploiting a medical tradition.
Dickson D
Nature; 1994 Dec; 372(6507):597. PubMed ID: 7990943
[No Abstract] [Full Text] [Related]
17. NIH drops reasonable pricing clause.
Gavaghan H
Nature; 1995 Apr; 374(6524):669. PubMed ID: 7715715
[No Abstract] [Full Text] [Related]
18. Uneasy alliance--clinical investigators and the pharmaceutical industry.
Bodenheimer T
N Engl J Med; 2000 May; 342(20):1539-44. PubMed ID: 10816196
[No Abstract] [Full Text] [Related]
19. Academic medical research: will collaboration with industry and national laboratories save it?
Eaton RP
Pharos Alpha Omega Alpha Honor Med Soc; 1995; 58(4):2-4. PubMed ID: 8539272
[No Abstract] [Full Text] [Related]
20. [Medical research, an enterprise in creativity at the incentive of needs: a plea for an interuniversity fund of pharmacologic research].
Christophe J
Rev Med Brux; 1981 Apr; 2(4):347-52. PubMed ID: 7291791
[No Abstract] [Full Text] [Related]
[Next] [New Search]
